151 related articles for article (PubMed ID: 15779232)
1. Reduced apoptosis rates in human schwannomas.
Utermark T; Kaempchen K; Antoniadis G; Hanemann CO
Brain Pathol; 2005 Jan; 15(1):17-22. PubMed ID: 15779232
[TBL] [Abstract][Full Text] [Related]
2. Generation and Use of Merlin-Deficient Human Schwann Cells for a High-Throughput Chemical Genomics Screening Assay.
Petrilli AM; Fernández-Valle C
Methods Mol Biol; 2018; 1739():161-173. PubMed ID: 29546707
[TBL] [Abstract][Full Text] [Related]
3. The neurofibromatosis type 2 gene product, merlin, reverses the F-actin cytoskeletal defects in primary human Schwannoma cells.
Bashour AM; Meng JJ; Ip W; MacCollin M; Ratner N
Mol Cell Biol; 2002 Feb; 22(4):1150-7. PubMed ID: 11809806
[TBL] [Abstract][Full Text] [Related]
4. Isolation and characterization of Schwann cells from neurofibromatosis type 2 patients.
Rosenbaum C; Kluwe L; Mautner VF; Friedrich RE; Müller HW; Hanemann CO
Neurobiol Dis; 1998 Jul; 5(1):55-64. PubMed ID: 9702788
[TBL] [Abstract][Full Text] [Related]
5. Cellular mechanisms of heterogeneity in NF2-mutant schwannoma.
Chiasson-MacKenzie C; Vitte J; Liu CH; Wright EA; Flynn EA; Stott SL; Giovannini M; McClatchey AI
Nat Commun; 2023 Mar; 14(1):1559. PubMed ID: 36944680
[TBL] [Abstract][Full Text] [Related]
6. Combination Therapy with c-Met and Src Inhibitors Induces Caspase-Dependent Apoptosis of Merlin-Deficient Schwann Cells and Suppresses Growth of Schwannoma Cells.
Fuse MA; Plati SK; Burns SS; Dinh CT; Bracho O; Yan D; Mittal R; Shen R; Soulakova JN; Copik AJ; Liu XZ; Telischi FF; Chang LS; Franco MC; Fernandez-Valle C
Mol Cancer Ther; 2017 Nov; 16(11):2387-2398. PubMed ID: 28775147
[TBL] [Abstract][Full Text] [Related]
7. Transduction of wild-type merlin into human schwannoma cells decreases schwannoma cell growth and induces apoptosis.
Schulze KM; Hanemann CO; Müller HW; Hanenberg H
Hum Mol Genet; 2002 Jan; 11(1):69-76. PubMed ID: 11773000
[TBL] [Abstract][Full Text] [Related]
8. Ruffling membrane, stress fiber, cell spreading and proliferation abnormalities in human Schwannoma cells.
Pelton PD; Sherman LS; Rizvi TA; Marchionni MA; Wood P; Friedman RA; Ratner N
Oncogene; 1998 Oct; 17(17):2195-209. PubMed ID: 9811451
[TBL] [Abstract][Full Text] [Related]
9. Ponatinib promotes a G1 cell-cycle arrest of merlin/NF2-deficient human schwann cells.
Petrilli AM; Garcia J; Bott M; Klingeman Plati S; Dinh CT; Bracho OR; Yan D; Zou B; Mittal R; Telischi FF; Liu XZ; Chang LS; Welling DB; Copik AJ; Fernández-Valle C
Oncotarget; 2017 May; 8(19):31666-31681. PubMed ID: 28427224
[TBL] [Abstract][Full Text] [Related]
10. Peroxynitrite supports a metabolic reprogramming in merlin-deficient Schwann cells and promotes cell survival.
Pestoni JC; Klingeman Plati S; Valdivia Camacho OD; Fuse MA; Onatunde M; Sparrow NA; Karajannis MA; Fernández-Valle C; Franco MC
J Biol Chem; 2019 Jul; 294(30):11354-11368. PubMed ID: 31171721
[TBL] [Abstract][Full Text] [Related]
11. Rac1 is required for Prkar1a-mediated Nf2 suppression in Schwann cell tumors.
Manchanda PK; Jones GN; Lee AA; Pringle DR; Zhang M; Yu L; La Perle KM; Kirschner LS
Oncogene; 2013 Jul; 32(30):3491-9. PubMed ID: 23045281
[TBL] [Abstract][Full Text] [Related]
12. The importance of nerve microenvironment for schwannoma development.
Schulz A; Büttner R; Hagel C; Baader SL; Kluwe L; Salamon J; Mautner VF; Mindos T; Parkinson DB; Gehlhausen JR; Clapp DW; Morrison H
Acta Neuropathol; 2016 Aug; 132(2):289-307. PubMed ID: 27236462
[TBL] [Abstract][Full Text] [Related]
13. Molecular Analysis of Hybrid Neurofibroma/Schwannoma Identifies Common Monosomy 22 and α-T-Catenin/CTNNA3 as a Novel Candidate Tumor Suppressor.
Stahn V; Nagel I; Fischer-Huchzermeyer S; Oyen F; Schneppenheim R; Gesk S; Bohring A; Chikobava L; Young P; Gess B; Werner M; Senner V; Harder A
Am J Pathol; 2016 Dec; 186(12):3285-3296. PubMed ID: 27765635
[TBL] [Abstract][Full Text] [Related]
14. Merlin status regulates p75(NTR) expression and apoptotic signaling in Schwann cells following nerve injury.
Ahmad I; Fernando A; Gurgel R; Jason Clark J; Xu L; Hansen MR
Neurobiol Dis; 2015 Oct; 82():114-122. PubMed ID: 26057084
[TBL] [Abstract][Full Text] [Related]
15. Loss of the NF2 gene and merlin occur by the tumorlet stage of schwannoma development in neurofibromatosis 2.
Stemmer-Rachamimov AO; Ino Y; Lim ZY; Jacoby LB; MacCollin M; Gusella JF; Ramesh V; Louis DN
J Neuropathol Exp Neurol; 1998 Dec; 57(12):1164-7. PubMed ID: 9862639
[TBL] [Abstract][Full Text] [Related]
16. Pathological adhesion of primary human schwannoma cells is dependent on altered expression of integrins.
Utermark T; Kaempchen K; Hanemann CO
Brain Pathol; 2003 Jul; 13(3):352-63. PubMed ID: 12946024
[TBL] [Abstract][Full Text] [Related]
17. Interdomain binding mediates tumor growth suppression by the NF2 gene product.
Sherman L; Xu HM; Geist RT; Saporito-Irwin S; Howells N; Ponta H; Herrlich P; Gutmann DH
Oncogene; 1997 Nov; 15(20):2505-9. PubMed ID: 9395247
[TBL] [Abstract][Full Text] [Related]
18. Universal absence of merlin, but not other ERM family members, in schwannomas.
Stemmer-Rachamimov AO; Xu L; Gonzalez-Agosti C; Burwick JA; Pinney D; Beauchamp R; Jacoby LB; Gusella JF; Ramesh V; Louis DN
Am J Pathol; 1997 Dec; 151(6):1649-54. PubMed ID: 9403715
[TBL] [Abstract][Full Text] [Related]
19. Impaired intercellular adhesion and immature adherens junctions in merlin-deficient human primary schwannoma cells.
Flaiz C; Utermark T; Parkinson DB; Poetsch A; Hanemann CO
Glia; 2008 Apr; 56(5):506-15. PubMed ID: 18240308
[TBL] [Abstract][Full Text] [Related]
20. Immunoblotting analysis of schwannomin/merlin in human schwannomas.
Harwalkar JA; Lee JH; Hughes G; Kinney SE; Golubić M
Am J Otol; 1998 Sep; 19(5):654-9. PubMed ID: 9752976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
